Total raised
$90.0M
Last: Undisclosed 2022-12
Stage
Series C
Founded
2015
Headcount
47
HQ
Tel Aviv-Yafo
Sector
Health Tech & Life Sciences
About
DayTwo is a microbiome-based precision health company committed to creating individualized solutions for the epidemic of chronic conditions, starting with diabetes, prediabetes, and clinical obesity.
Using the highest resolution microbiome analysis available and a unique artificial intelligence-based algorithm, DayTwo can accurately predict blood sugar response to foods or food combinations– before people even take a bite. Its clinically proven approach is based on the company's proprietary microbiome dataset. With over 85,000 samples, it is one of the largest and richest in the world.
Funding history · 7 rounds · $90.0M total
2022-12
Undisclosed
Undisclosed
2021-05
Series C
$37.0M
2019-10
Series B
$5.0M
2019-06
Series B
$31.0M
2018-06
Undisclosed
Undisclosed
2017-06
Series A
$12.0M
2016-05
Seed
$5.0M
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Therapeutics
Technologies
Platforms & InterfacesMobileArtificial IntelligenceMachine LearningBiologicalsMicroorganisms
Target customers
Enterprise & Professional ServicesHuman Resource & Employment ServicesConsumersRecreational & LifestyleHealthcare & Life SciencesHealthcarePatientsProviders
Business model
B2B2CB2BB2C
Highlights
1 PatentsVerified
Tags
personalizationfoodtechchronic-diseasedigital-healthcareobesitymhealthnutritionmachine-learningdiabetesmobile-applicationstype-2-diabetesdata-analyticsactionable-insightsprecision-medicinemicrobiomeartificial-intelligencenutrition-advicedigital-therapeuticsinsurance-companiesclinicshealthcare-providerspatients